Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New EGFR inhibitors identified by Ariad scientists

Aug. 23, 2004

Fast track status for temsirolimus for first-line treatment of advanced RCC

Aug. 19, 2004

MediGene acquires anticancer drugs and technology of Munich Biotech

Aug. 19, 2004

Abbott presents new Bcl-targeting agents with potential in cancer chemotherapy

Aug. 18, 2004

FDA and Genentech issue warning on Avastin

Aug. 18, 2004

New HSP90 inhibitors and their use in cancer and other disorders

Aug. 18, 2004

Swiss approval for Femara as extended adjuvant treatment

Aug. 18, 2004

Combined immunostimulatory treatment enhances antitumor activity in vivo

Aug. 18, 2004

NeuroSearch and TopoTarget collaborate on Endovion development

Aug. 17, 2004

Spectrum acquires North American, Indian rights to D-631153

Aug. 17, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...